0.083
10.08%
-0.0093
After Hours:
.08
-0.003
-3.61%
Elevai Labs Inc stock is traded at $0.083, with a volume of 11.56M.
It is down -10.08% in the last 24 hours and down -68.84% over the past month.
See More
Previous Close:
$0.0923
Open:
$0.089
24h Volume:
11.56M
Relative Volume:
2.86
Market Cap:
$2.21M
Revenue:
$1.44M
Net Income/Loss:
$-3.21M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-21.99%
1M Performance:
-68.84%
6M Performance:
-88.06%
1Y Performance:
+0.00%
Elevai Labs Inc Stock (ELAB) Company Profile
Name
Elevai Labs Inc
Sector
Industry
Phone
18667944940
Address
120 NEWPORT CENTER DRIVE, NEWPORT BEACH
Elevai Labs Inc Stock (ELAB) Latest News
What is ELAB’s price-to-sales ratio telling us about the company’s value? - US Post News
Elevai Labs Inc. [ELAB] Revenue clocked in at $2.47 million, down -94.95% YTD: What’s Next? - The DBT News
In the Green: Elevai Labs Inc. (ELAB) Closes at 0.09, Up/Down 3.71 from Previous Day - The Dwinnex
Elevai Labs Inc.’s Banking’s 100-Day Moving Average at 0.4636: Will the Stock Break Through? - The InvestChronicle
Biotech Alert: Searches spiking for these stocks today - TipRanks
Altium Capital Management LP Acquires New Stake in Elevai Labs Inc - Yahoo Finance
Elevai Labs stock offering raises $8 million - The Business Journals
Altium Capital Management LP Acquires New Stake in Elevai Labs I - GuruFocus.com
Univest Securities, LLC Announces Closing of $8.0 Million - GlobeNewswire
Univest Securities, LLC Announces Closing of $8.0 Million Registered Follow-on Offering for its Client Elevai Labs Inc. (NASDAQ: ELAB) - ForexTV.com
Evolus Inc (EOLS) may enjoy gains as insiders got busy in the recent days - Knox Daily
Univest Securities, LLC Announces Closing of $8.0 Million Registered Follow-on Offering for its Client Elevai Labs Inc. (NASDAQ: ELAB) - Yahoo Finance UK
Evolv Technologies (NASDAQ:EVLV) Shares Down 2.9% - Defense World
EverSource Wealth Advisors LLC Raises Stock Position in Elevance Health, Inc. (NYSE:ELV) - Defense World
Enliven Therapeutics (NASDAQ:ELVN) Shares Gap Down to $23.57 - MarketBeat
Logos Global Management LP Lowers Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
First Light Asset Management LLC Has $27.63 Million Stake in Evolent Health, Inc. (NYSE:EVH) - Defense World
Evolv Technologies Holdings Inc (EVLV) looking to reclaim success with recent performance - SETE News
Stock Market Recap: Evolus Inc (EOLS) Concludes at 15.53, a -6.16 Surge/Decline - The Dwinnex
Check out these key findings about Elevation Oncology Inc (ELEV) - SETE News
SEC Form 424B3 filed by Elevai Labs Inc. - Quantisnow
Lombard Odier Asset Management Europe Ltd Invests $2.51 Million in Elevance Health, Inc. (NYSE:ELV) - Defense World
What is Elevai Labs Inc. (ELAB) Stock Return on Shareholders’ Capital? - SETE News
Pacer Advisors Inc. Decreases Stock Position in Elevance Health, Inc. (NYSE:ELV) - Defense World
Distillate Capital Partners LLC Grows Position in Elevance Health, Inc. (NYSE:ELV) - MarketBeat
Rhumbline Advisers Acquires 17,442 Shares of Evolus, Inc. (NASDAQ:EOLS) - Defense World
Victory Capital Management Inc. Sells 414,447 Shares of Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Elementis (OTCMKTS:ELMTY) Sets New 52-Week High at $8.76 - Defense World
Elevai Labs shares tumble on pricing of new stock offering - The Business Journals
Elevance Health, Inc. (NYSE:ELV) Position Boosted by Magnetar Financial LLC - Defense World
Dow Gains Over 50 Points; Elevai Labs Shares Plummet - Benzinga
Decoding Elevance Health's Options Activity: What's the Big Picture? - Benzinga
Elevai Labs Inc. (ELAB) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
ELAB’s price-to-free cash flow ratio: What it means for investors - US Post News
Perhaps timely catching Enliven Therapeutics Inc (ELVN) would be a good idea - SETE News
Ratios in Focus: Analyzing Elevation Oncology Inc (ELEV)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Elevai Labs prices public offering at $8 million By Investing.com - Investing.com Canada
Why Elevai Labs (ELAB) Stock Is Down 60% Today - Benzinga
Investing in Elevation Oncology Inc (ELEV) might be a great opportunity, but the stock is a bit undervalued - US Post News
Baltic Fintech Eleving To Raise Up To €30M In IPO - Law360
Xponance Inc. Sells 168 Shares of Elevance Health, Inc. (NYSE:ELV) - Defense World
Elevai Labs prices public offering at $8 million - Investing.com
Market Highlights: Elevai Labs Inc. (ELAB) Ends on a Low Note at 0.28 - The Dwinnex
Elevai Labs announces pricing of $8 million public offering - MSN
Elevai Labs to sell 28.6M shares at 28c in public offering - TipRanks
Ensign Peak Advisors Inc Acquires 2,862 Shares of Elevance Health, Inc. (NYSE:ELV) - Defense World
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering - The Bakersfield Californian
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering - GlobeNewswire
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering - StockTitan
Elevar Therapeutics Resubmits New Drug Application to FDA for Combination of Camrelizumab plus Rivoceranib as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma Boosted by CARES-310 Leading Overall Survival Analysis - ForexTV.com
How should investors view Evolv Technologies Holdings Inc (EVLV)? - US Post News
Elevai Labs Inc Stock (ELAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):